Anthony J. Recupero Sells 3,937 Shares of SI-BONE, Inc. (NASDAQ:SIBN) Stock

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,937 shares of the firm’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $12.60, for a total value of $49,606.20. Following the sale, the insider now owns 228,554 shares of the company’s stock, valued at $2,879,780.40. This represents a 1.69 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

SI-BONE Stock Performance

Shares of NASDAQ SIBN opened at $12.31 on Friday. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The firm’s 50-day moving average price is $13.79 and its two-hundred day moving average price is $14.23. SI-BONE, Inc. has a 52-week low of $11.70 and a 52-week high of $21.70. The stock has a market capitalization of $516.24 million, a P/E ratio of -13.38 and a beta of 1.22.

Analysts Set New Price Targets

SIBN has been the subject of several recent analyst reports. Truist Financial raised their target price on SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Morgan Stanley decreased their price target on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $19.00 price target on shares of SI-BONE in a research note on Wednesday. Six analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $23.00.

Hedge Funds Weigh In On SI-BONE

A number of large investors have recently bought and sold shares of the business. Barclays PLC lifted its holdings in SI-BONE by 190.8% in the third quarter. Barclays PLC now owns 96,623 shares of the company’s stock worth $1,350,000 after acquiring an additional 63,402 shares during the last quarter. Geode Capital Management LLC lifted its holdings in SI-BONE by 3.4% in the third quarter. Geode Capital Management LLC now owns 924,044 shares of the company’s stock worth $12,921,000 after acquiring an additional 30,005 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in SI-BONE in the third quarter worth about $448,000. Pier Capital LLC raised its holdings in shares of SI-BONE by 23.6% during the third quarter. Pier Capital LLC now owns 465,898 shares of the company’s stock valued at $6,513,000 after buying an additional 88,897 shares during the last quarter. Finally, Jane Street Group LLC raised its holdings in shares of SI-BONE by 29.0% during the third quarter. Jane Street Group LLC now owns 77,359 shares of the company’s stock valued at $1,081,000 after buying an additional 17,410 shares during the last quarter. Institutional investors own 98.11% of the company’s stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.